Related Experiment Video
Updated: Jul 14, 2026

Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
Diminished zonula occludens-1 expression in the failing human heart
James G Laing1, Jeffrey E Saffitz, Thomas H Steinberg
1Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. laing@id.wustl.edu
Insights
Reduced zonula occludens-1 (ZO-1) expression in heart failure disrupts connexin 43 (Cx43) gap junctions, potentially causing arrhythmias and sudden cardiac death. This study investigated ZO-1 levels in failing human hearts.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Physiology
Background:
- Reduced expression of connexin 43 (Cx43) in heart failure is linked to arrhythmias.
- Zonula occludens-1 (ZO-1) interacts with Cx43 and regulates gap junction formation and function.
- The role of ZO-1 in Cx43 gap junction assembly and function in the failing heart requires investigation.
Purpose of the Study:
- To determine if ZO-1 expression is altered in patients with heart failure.
- To investigate the relationship between ZO-1 and Cx43 in failing human hearts.
Main Methods:
- Immunohistochemistry was used to examine ZO-1 expression in ventricular myocardium from end-stage heart failure patients and controls.
- Immunoblotting was performed on heart tissue lysates to quantify ZO-1 protein levels.
Main Results:
- ZO-1 was present at 96% of intercalated discs in control hearts, colocalizing with Cx43.
- In failing hearts, ZO-1 was found at only 5% of intercalated discs, with reduced Cx43 staining.
- Immunoblotting revealed a 95% reduction in ZO-1 expression in human heart failure.
Conclusions:
- Loss of ZO-1 at intercalated discs in heart failure correlates with Cx43 reduction.
- Altered ZO-1 and Cx43 expression may lead to gap junction remodeling, abnormal impulse propagation, and arrhythmogenesis.
- These changes likely contribute to sudden cardiac death risk in heart failure patients.
Background:
Reduced expression of the major gap junction protein connexin 43 (Cx43) in the failing human heart may lead to arrhythmias and sudden cardiac death. Cx43 interacts with the actin binding protein, zonula occludens-1 (ZO-1), and it has recently been demonstrated that ZO-1 regulates the formation and function of Cx43 gap junctions. We hypothesize that normal expression of ZO-1 and its interaction with Cx43 are required for appropriate assembly and function of Cx43 gap junctions in the heart. Here, we determined whether expression of ZO-1 is altered in patients with heart failure.
Methods:
We examined ventricular myocardium from hearts of patients in end-stage heart failure, obtained at transplant, for ZO-1 expression by immunohistochemistry. We also subjected lysates made from this tissue to immunoblotting to determine the level of ZO-1 expression.
Results And Conclusions:
ZO-1 was found at 96% of the intercalated discs in nonfailing control human hearts, where it colocalized with Cx43. In contrast, there was ZO-1 immunostaining at 5% of intercalated discs in failing hearts, coincident with a reduction in Cx43 staining in intercalated discs. Immunoblotting analysis showed that there was a 95% reduction in ZO-1 expression in human heart failure. Loss of ZO-1 at intercalated discs in heart failure may play a critical role in remodeling of Cx43 gap junctions, which may contribute to abnormal impulse propagation and arrhythmogenesis, thereby predisposing patients in heart failure to sudden cardiac death.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

